Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Treatment options for moderate and severe asthma

Thematic Poster Session
Chairs: E. Nizankowska (Krakow, Poland), J. C. Virchow (Rostock, Germany)


Download all media Download all media
 [+]  Congress or journal article abstract 417 Long-term asthma control with omalizumab, an anti-IgE monoclonal antibody, in patients with severe allergic asthma
K. Chung, J. Ankerst, M. Rolli, J. Gao, C. Reisner (London, United Kingdom; Lund, Sweden; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 418 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age
R. Buhl, H. Fox, M. Blogg, C. Reisner (Mainz, Germany; Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 419 Omalizumab significantly improves FEV1 in patients with severe persistent allergic asthma: a pooled analysis
S. Holgate, H. Fox, S. Hedgecock, P. Freeman, C. Reisner (Southampton, Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 420 Improved disease control in asthmatics treated with daclizumab is not associated with changes in allergen-specific or total IgE
W. W. Busse, E. Israel, H. E. Nelson, V. Vexler, M. H. Wang, R. S. Shames (Madison, Boston, Denver, Fremont, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 421 Long-term safety and tolerability of omalizumab, an anti-IgE monoclonal antibody, in patients with severe allergic asthma
A. Chuchalin, J. Herbert, M. Rolli, J. Gao, C. Reisner (Moscow, Russian Federation; , ; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 422 Evaluating response to omalizumab (anti-IgE) in clinical practice
G. Ayre, H. Fox, H. Chen, S. Hedgecock, C. Reisner (Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 423 Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis
M. Humbert, H. Fox, S. Hedgecock, G. Ayre, P. Freeman, C. Reisner (Clamart, France; Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 424 Omalizumab significantly improves quality of life in patients with severe persistent allergic asthma: a pooled analysis
K. M. Beeh, H. Fox, P. Freeman, S. Hedgecock, C. Reisner (Wiesbaden, Germany; Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 425 Effect of lidocaine delivered by a hand-held metered-dose inhaler on steroid-resistant asthma
K. Yin, X. Zhang (Nanjing, China)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 426 Effect of tiotropium bromide as an additional therapy in severe intractable asthmatics
N. Suzuki, K. Ito, N. Yoshida, S. Hoshi, C. Ogawa, Y. Sano (Tokyo, Japan)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 427 Mycophenolate mofetil: an effective corticosteroid-sparing drug in steroid-dependent asthma
S. Minder, J. E. Salomon, C. Mordasini, L. P. Nicod (Bern, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 428 The inhalations of low-doses of cyclosporin A for bronchial asthma treatment
K. A. Zykov, S. N. Lebedev, A. V. Rvacheva, L. J. Matko, V. I. Shevelev, A. L. Pukhalsky, E. I. Kaznacheeva, E. I. Sokolov (Moscow, Russian Federation)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 429 Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma
Y. To, M. Ito, I. M. Adcock, P. J. Barnes, K. Ito (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 430 Formoterol delivered by multi-dose dry powder inhaler (MDDPI) improves nocturnal asthma symptoms
W. Busse, C. LaForce, D. Till, S. Stenglein (Madison, Raleigh, United States Of America; Horsham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 431 Adjustable dosing with budesonide/formoterol achieves sustained guideline ‘well-controlled asthma‘ following step down in treatment
R. Aalbers, A. Harris, I. Naya (Groningen, Netherlands; Lund, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 432 Maintenance plus as-needed budesonide/formoterol is cost-effective compared with dose-titrated salmeterol/fluticasone
G. Johansson, P. E. Larsson, E. Andreasson (Uppsala, Lund, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 433 Comparability of formoterol dry powder (DPI) and metered dose inhalers (MDI) in asthma
B. J. Lipworth, S. K. Das, A. H. Morice, B. J. O‘Connor (Dundee, St Albans, Hull, London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 434 No evidence for increase in serious asthma exacerbations with formoterol 24 μg twice daily
J. Wolfe, C. LaForce, B. Ziehmer, C. Orevillo, D. Till (San Jose, Raleigh, East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 435 Comparable efficacy and tolerability of formoterol 12 μg or 24 μg twice daily in asthma patients
B. Friedman, W. Sokol, B. Ziehmer, C. Orevillo, D. Till (Fountain Valley, Newport Beach, East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 436 Can control of severe asthma be achieved?
A. Bourdin, L. Halimi, P. Godard, P. Chanez (Montpellier, France)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite